PANCREATIC CARCINOMA RECURRENT

This adverse event was reported 241 times

These drugs are most commonly taken by patients reporting PANCREATIC CARCINOMA RECURRENT:

# Drug Count
0 PANCRELIPASE 68
1 GEMCITABINE HYDROCHLORIDE 28
2 GEMCITABINE 25
3 FLUOROURACIL 24
4 FLUOROURACIL CREAM, 0.5% 24
5 SITAGLIPTIN 22
6 PACLITAXEL 19
7 OXALIPLATIN 17
8 LANSOPRAZOLE 13
9 PACLITAXEL (AIBUMIN-BOUND) 13
See all common drugs associated with PANCREATIC CARCINOMA RECURRENT

PANCREATIC CARCINOMA RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PACKERA AUREA 1 0.5000
1 SENNA 8.6MG 1 0.0185
2 ACID REDUCER 1 0.0039
3 FAMOTIDINE 20MG 1 0.0027
4 PANCRELIPASE 68 0.0017
5 MIRIKIZUMAB-MRKZ 1 0.0011
6 METYRAPONE 1 0.0010
7 ALDESLEUKIN 1 0.0008
8 ETHIODIZED OIL 1 0.0008
9 PSYLLIUM HUSK 1 0.0007
See all drugs enriched for association with PANCREATIC CARCINOMA RECURRENT

PANCREATIC CARCINOMA RECURRENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Adrenal Steroid Synthesis Inhibitor [EPC] 1 0.0010
1 Lymphocyte Growth Factor [EPC] 1 0.0008
2 Interferon gamma [EPC] 1 0.0007
3 Antihypoglycemic Agent [EPC] 2 0.0005
4 CCR5 Co-receptor Antagonist [EPC] 1 0.0004
5 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 8 0.0004
6 Cannabinoid [EPC] 2 0.0002
7 Provitamin D2 Compound [EPC] 7 0.0002
8 Phenothiazine [EPC] 7 0.0002
9 Bile Acid [EPC] 5 0.0002
See all drug classes enriched for association with PANCREATIC CARCINOMA RECURRENT